Introduction
Fibre-optic bronchoscopy with bronchoalveolar lavage (BAL) is commonly used in the investigation of various pulmonary diseases (1, 2) . In recent years, BAL has been used increasingly to investigate the basic mechanisms of bronchial asthma, and numerous publications have been devoted to the use of bronchoscopy with BAL in asthmatic patients (3) (4) (5) (6) (7) (8) .
The safety of bronchoscopic procedures in the asthmatic patient has been a matter of obvious concern. Short-term reduction in pulmonary function (forced expiratory volume in 1 s = FEV,; forced vital capacity, FVC) has been demonstrated after the procedure (9) (10) (11) (12) (13) . Some authors have suggested that bronchoconstriction is the principal mechanism causing a more marked fall in FEV, in asthmatic subjects (11) ; whereas others, in contrast, suggested a more restrictive reduction in lung function (13) . Some investigators have found a more marked decrease in oxygen saturation in patients with mild asthma than in normal subjects (1 l), whereas others have shown no differences in BAL-associated desaturation between asthmatics' and normal subjects (13) . In these studies (11, 13) , using digital oximetry. oxygen saturation returned to normal soon after termination of the procedure. The analysis of arterial blood gases represents a more precise technique for examining the effects of BAL on lung function. Moreover the analysis of arterial oxygen partial pressure (PaO,) and arterial carbon dioxide (PaCO,) gives information on the perfusionventilation relationship through the behaviour of alveolar arterial (A-a) oxygen tension gradient. To the authors' knowledge, no studies have analysed the behaviour of arterial blood gases and (A-a) gradient associated with BAL in asthmatics, and monitored arteial blood gases for a period of up to 24 h after BAL. The aims of this study were to(l) record the changes of PaO,, PaCO, and (A-a) gradient resulting from BAL in asthmatics during and up to 24 h after the procedure; (2) measure changes in FEV, and FVC associated with BAL; and (3) assess possible predictive factors for the degree of hypoxaemia and impairment of spirometry resulting from BAL in asthmatics.
Methods

STUDY POPULATION
Twenty-eight asthmatics were enrolled in the study. Two of them were excluded from data analysis because the endoscopic procedure was suspended due to severe dyspnoea, and they were given inhaled salbutamol and intravenous theophylline. Two more subjects were excluded because it proved impractical to collect arterial blood sample. The data of 24 asthmatic subjects aged 58 * 10 years were analysed (Table 1) . Asthma was defined according to the criteria of the American Thoracic Society (14) . All subjects had a clinical history of intermittent wheeze, cough, chest tightness or dyspnoea, and documented reversible airway limitation either spontaneously or with treatment in the preceeding year.
Subjects' FEV, and FVC was, respectively, 79.1 k 16.3 and 94.0 f 10.4, expressed as mean + SD of predicted value % (15) . None of the subjects were current smokers and none had smoked within the previous 3 years. None of the subjects were taking oral steroids or long-acting &agonists. Nine subjects were taking inhaled steroids. The clinical severity of asthma was assessed according to the scoring system of Aas (16) . Fifteen non-smoking subjects aged 54 f 12 years were studied (Table l) , recruited from subjects who were referred to the asthma clinic for subjective breathless or periodic cough and had negative investigations. They came to the laboratory on three occasions. On Day 1, spirometry, chest X-ray and peak expiratory flow (PEF) monitoring were performed and all subjects gave their written consent. On Day 2, methacoline challenge was performed and 1 week later (Day 3), bronchoscopy was performed. No subject presented any respiratory symptom at the time of bronchial challenge or bronchoscopy. Mean FEV, was 1053 & 10.8 (% predicted), FEV was 110.1 & 12.7, and mean PEF daily variability (highest PEF -lowest PEF/highest PEF x 100) was <lo%, over a monitoring period of 2 weeks before the endoscopic procedure, using a Wright peak flow meter (Markos, Monza, Italy) (17) . Provocative dose of methacholine for a 20% fall in FEV, (PD& was ~1.5 mg in all healthy subjects.
Bronchial challenge with methacholine was performed according to a method modified from the SEPCR working group guidelines to calculate the PD,, (15) . The solutions were administered by nebulizer (Mefar MB3, Bavezzo, Brescia, Italy), and PD,, was calculated by interpolation. The study was approved by the Ethics Committee of Fondazione Salvatore Maugeri, and all subjects gave written informed consent.
PULMONARY FUNCTION
Pulmonary function was assessed with a dry wedge spirometer (Vitalograph, Buckinghamshire, U.K.) by measuring FEV, and FVC. At least three measurements were obtained and the values associated with the best FEV, were recorded by the same operator (PG). Spirometry was performed just before and 5 min after endoscopic procedure was completed. /$ agonist (Salbutamol) was withheld for at least 8 h before testing.
ENDOSCOPIC PROCEDURE
Pre-medication consisted of intramuscular atropine (0.5 mg), intramuscular diazepam (5 mg) and local anaesthesia with 2% lignocaine applied to the upper respiratory tract in all subjects. With the subjects in a supine position, an Olympus BFlT20 bronchoscope (Olympus Optical Co., Tokyo, Japan) was introduced through the mouth, and 1% lignocaine solution was administered through the bronchoscope channel to provide anaesthesia for the airways below the vocal cords. Duration of the procedure was timed from intubation of the vocal cords until extraction of the bronchoscope using an electric timer (Casio 376, ARW-320, Japan). The airways were systematically examined, the bronchoscope was wedged into one of the subsegmental bronchi of the middle lobe and BAL was performed using three aliquots of 50 ml saline pre-warmed at 37°C
re-aspirated by gentle 50 ml syringe suction by the same operator (PG) for all bronchoscopies. During bronchoscopy, oxygen, electrocardiographic monitoring and full resuscitation were readily available and the patient had an intravenous infusion to provide venous access. During the procedure, HbO, saturation was continuously monitored in all subjects using oxymetry (Pulsox 7-Minolta; AVL AG, SchaIIhausen, CH) with a finger probe. All subjects were given salbutamol 3OOpg by metered-dose inhaler, immediately after the collection of arterial blood sample, 15 min after endoscopic procedure. Asthmatics restarted therapy that they were taking after the arterial blood gas analysis perfomed 8 h after the end of the endoscopic procedure. The protocol called for the procedure to be terminated if either the patient had severe asthma symptoms of HbO, saturation (monitored by oximetry) fell below 80%. In this case, oxygen would have been administered and bronchodilator therapy given.
ARTERIAL BLOOD GAS ANALYSES
Ten arterial blood samples were obtained for each subject at the following times (T): T, before and T, after local anaesthesia with 2% lignocaine;
T, at end of routine bronchoscopy when the bronchoscope was wedged ready for BAL, T, at end of BAL with the bronchoscope still wedged, T, 5 min and T, 15 min after the end of the procedure; and T,, T,, T,, T,, (respectively) 1, 2, 8 and 24 h after the end of the procedure.
All the arterial blood samples were obtained by the same operator (GBM) using a syringe (Microsample-AVL, Schaffausen, CH) with a thin needle (Microlance 256, 0.5 x 16, Dublin, Ireland). Arterial blood gas analyses were performed immediately on an ABL 330 (Radiometer, Copenhagen, Denmark) blood gas analyser situated in the same room where bronchoscopy was performed.
PREDICTIVE FACTORS FOR HYPOXAEMIA AND IMPAIRMENT OF SPIROMETRY
For the analysis of predictive factors, the authors correlated PaO, at time T,, basal FEV, measured before bronchoscopy and Aas score with the lowest value of PaO, occurring in asthmatics during the procedure, and the percentage fall in FEV, caused by the procedure.
STATISTICAL ANALYSIS
All the evaluated parameters were analysed by descriptive statistics. FEV, and FVC were expressed as a percentage of predicted value (15) . SaO, as percentage, PaO,, PaCO, and (A-u) gradient are in kiloPascals (kPa). The distribution of the different parameters (FEV,; FVC; PaO,; PaCO,) was evaluated for normality using the Statgraphics Statistical Package, version 7. Since the data were normally distributed, parametric tests were used. To detect differences concerning a variable measured at different times, ANOVA for repeated measurements was applied (multifactor ANOVA procedure of Statgraphics). Student's t-test with Bonferroni correction was applied to detect significant changes in PaO,, PaCO,, SaO, and (A-a) gradient in the same subject (paired) or between two groups (unpaired). To detect differences concerning FEV,, FVC and FEV,/FVC in the same subjects, Student's paired t-test was used. To evaluate the difference between groups, Student's unpaired t-test was applied. Correlation coefficients, to study the association between two variables, were calculated by linear regression. A P value<0.05 was considered statistically significant. PaO, values (7.10 f 0.60) reached in asthmatics (at T, or T,) was significantly lower than that in control subjects compared (7.75 * 0.47; P<O.O5). A significant fall in PaCO, was observed from T, to T, in asthmatic and healthy subjects. A significant increase in (A-cl) gradient was observed from T, to T,-, in asthmatic and healthy subjects. The width of (A-a) gradient was not significantly different between the two groups at different times (T,-T,,). There was no significant difference between the mean values of minimum PaO, reached during bronchoscopy in asthmatics treated with inhaled steroids (PaOz= 7.0 & 0.5) and asthmatics without inhaled steroids (Pa0,=7.2 f 0.6).
Results
BAL
PULMONARY FUNCTION
In asthmatic patients, FVC decreased significantly from 94.0 i 10.4 to 70.5 f 12.4% predicted (P<O.OOl), FEV, decreased significantly from 79.1 f 16.3 to 53.5 % 14.1% predicted (P<O.OOl) and the ratio FEV,/FVC decreased significantly from 68.0 * 9.8 to 61.5 f 10.1% (P<O.OOl; Fig. 1 Fig. 3 ). The fall in FEV, after the procedure was significantly higher in asthmatics than in healthy subjects (32.4 * 10.0 w 18.2 f 4.6%; I  I  I  I  I  I   TI  T2  T3  T4  T5  T,  T 
Discussion
This study assessed the behaviour of PaO,, PaCO, and (A-a) gradient during and up to 24 h after BAL, and showed changes in FEV, and FVC caused by BAL in both asthmatics and healthy subjects. In addition, possible factors predictive of the magnitude of 0, desaturation and impairment of spirometric values were assessed. There was a significant fall in PaO, and a significant widening of (A-a) gradient in both groups of subjects during and up to 8 h after the procedure. Asthmatics reached a significantly lower value of PaO,. PaCO, did not increase significantly at any time during the procedure. There was a decrease of FEV, and FVC after BAL in asthmatic and healthy subjects, but in asthmatics, the reduction in FEV, and FVC was significantly greater than in healthy subjects. In asthmatics, the magnitude of decrease of PaO, and FEV, was not predicted by the severity of asthma, baseline PaO, or basal FEV,.
In the present study, a significant fall in PaO, was observed at the end of routine bronchoscopy (T3) and at end of BAL (TJ with respect to the value of PaO, at baseline (T,) in both asthmatic and healthy subjects. BAL was performed using three 50 ml aliquots of sterile saline, prewarmed at 37"C, without bronchial biopsies, &agonist pre-treatment and oxygen administration. The present results differ from those obtained by Djukanovic et al. (11) who performed BAL (eight 20 ml aliquots of saline prewarmed to 37°C) and bronchial biopsies in asthmatics after albuteral and ipratropium bromide pre-medication and oxygen delivery during the procedure. They did not observe a significant decrease in oxygen saturation after BAL in asthmatic and normal subjects. Van Vyne et al. (13) performed BAL (five 50 ml aliquots of saline at room temperature) and bronchial biopsies in asthmatics and normals (18) in which patients with various pulmonary diseases, given supplemental oxygen, did not show a significant reduction in PaO,, while this occurred in patients who did not receive supplemental oxygen during two bronchial washes, totally 80 ml of normal saline at room temperature. In the present study, the minimum value of PaO, reached in asthmatics was significantly lower than that observed in healthy subjects. The authors can suggest the possible role played by the lower baseline value of PaO,, and lower fluid recovery observed in asthmatics. In fact, the difference in fluid recovery of asthmatics and healthy subjects might be one of the reasons determining different falls of PaO,, as suggested by Pirozynsky et al. (19) .
PaO, was significantly reduced 1, 2 and 8 h after the procedure, and at 5 and 15 min. In a previous study, Burns et al. (20) showed that healthy subjects lavaged with 1000 ml of room temperature saline developed abnormalities in their ventilation-perfusion relationships, which persisted for 668 h after lobar lavage. This fact could explain the persisting significant decrease of PaO, until after 8 h of BAL in the present study. Moreover, the authors have found a significant widening of (A-a) gradient during and after BAL in asthmatic and healthy groups resulting in a reduction of efficiency of respiratory gases exchange, with a low ventilationperfusion ratio, still present 8 h after the procedure. This could be explained by 'flooding' of saline of bronchoalveolar spaces. The present study showed a significant fall in FEV, and FVC after the endoscopic procedure with BAL in asthmatic and healthy subjects in line with other studies (9, 11, 13) .
Van Vyve et ul. found no change in FEV,IFVC ratio after the procedure in either asthmatics or control subjects, suggesting a more restrictive reduction in lung function. In the present study, all subjects experienced some restriction, demonstrated by a significant fall in FEV, and FVC in both asthmatics and healthy subjects. Moreover, a significant decrease in FEV,/FVC ratio was observed after BAL in asthmatics, whilst the ratio did not change in healthy subjects, suggesting a more obstructive reduction in lung function in asthmatics. This is emphasized by the more marked fall in FEV, in asthmatics. The more marked fall in FEV, in asthmatics may be related to the increased tendency (non-specific bronchial responsiveness) to bronchoconstriction after lignocaine and forced expiratory manoeuvre, e.g. coughing (21) or physical stimulation by the bronchoscope and BAL. The present authors did not observe a significant correlation between the lowest value of PaO, in asthmatics and baseline FEV, or the clinical severity of asthma, characterized by the Aas core, as found in previous studies (11, 13) . Furthermore, it was found that baseline PaO, value cannot be considered a predictive factor for hypoxaemia determined by BAL. Previous studies have shown that arterial 0, desaturation is dependent upon the volume of saline instilled (19, 20) and the duration of the procedure (19) but in the present study, the volume of lavage was constant in all subjects and there was no great variation in the time required to complete the procedure in any of the subjects or between the two groups studied. In conclusion, this study has shown that: (i) BAL produces a significant reduction of PaO, and an increased width of (A-a) gradient, without increasing PaCO, during and up to 8 h after BAL in asthmatic subjects with asthma of variable severity; (ii) the extent and time course of reduction of PaO, and the increased width of (A-a) gradient are similar in asthmatics and healthy subjects, but asthmatics reach a significantly lower value of PaO,; (iii) the fall in FEV, and FVC after BAL is significantly greater in asthmatics than in healthy subjects; (iii) the fall in PaO, and FEV, cannot be predicted by the severity of asthma, baseline PaO, and FEV,. Although this study has confirmed previous findings that BAL can be performed without &agonist, pre-medication and oxygen delivery during and after the procedure in asthmatics, the results have shown a significant decrease of PaO, lasting up to 8 h, a lower value of PaO, during the procedure and a mean reduction in FEV, of 32% demonstrating significant adverse effects which may not be apparent clinically. Therefore, the authors strongly support the recommendations of oxygen administration during bronchoscopy, and special caution and careful monitoring when BAL is undertaken in asthmatic subjects (22, 23) ; additionally the authors recommend that oxygen saturation should be frequently monitored after the end of the procedure, and that premedication with &agonists should be administered before the endoscopic procedure in asthmatics.
